Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
K
114450
vs
K
KOSPI 200
Over the past 12 months, KPX Lifescience Co Ltd has underperformed KOSPI 200, delivering a return of -9% compared to KOSPI 200's +116% growth.
Stocks Performance
114450 vs KOSPI 200
Performance Gap
114450 vs KOSPI 200
Performance By Year
114450 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
KPX Lifescience Co Ltd
Glance View
KPX Lifescience makes pharmaceutical ingredients and chemical products that sit upstream in the drug supply chain. It sells active ingredients, intermediates, and other life-science chemicals that drugmakers and other industrial customers use to produce medicines and related products. The company does not sell finished medicines directly to consumers; it earns money by supplying bulk materials to other manufacturers. Its main customers are pharmaceutical companies, distributors, and other businesses that need reliable ingredient supply and consistent product quality. In practice, KPX Lifescience is a manufacturer and supplier, so its business depends on turning raw materials into standardized ingredients that meet customer specifications. That makes it more of a behind-the-scenes industrial supplier than a brand-name drug company. What sets the business apart is its role in the supply chain: customers often rely on it for repeat orders of regulated inputs that must be made to exact standards. That creates a business built around manufacturing know-how, quality control, and long-term customer relationships rather than consumer marketing. For investors, the key idea is that KPX Lifescience makes money by selling essential building-block materials to the pharmaceutical industry.